FDA Investigator: Ivis L. Negron Torres

- Ivis L. Negron Torres first started conducting FDA inspections in 2000, with the last inspection in 2023. Over that time, Ivis L. Negron Torres has conducted 106 inspections at 94 companies across 102 sites.

Documents

FDA 483 AbbVie, Barceloneta | February 2020

Available - $199
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Dexcel Pharma, Or Akiva | July 2019

Available - $199
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Amgen Manufacturing Ltd, Juncos | 2023

Out-of-stock
Ivis L. Negron Torres
Human Drugs Form 483

FDA 483 Golden Lab LLC, Jacksonville | 2023

Out-of-stock
Ivis L. Negron Torres
Foods & Cosmetics Form 483

FDA 483 Miramar Cosmetic Inc, Doral | 2022

Out-of-stock
Ivis L. Negron Torres
Foods & Cosmetic Form 483

FDA 483 Abbvie Biotechnology Ltd., Barceloneta | 2020

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 ITEST plus s.r.o., Kladruby Nad Labem | 2019

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Arab Pharmaceutical Manufacturing Co PSC LTD, Amman | 2019

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company, Manati | 2017

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Abraxis Bioscience Llc, Phoenix | 2016

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Patheon Italia S.p.A., Monza | 2016

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Merck Serono S.p.A., Modugno | 2016

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Abbvie Biotechnology Ltd., Barceloneta | 2016

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Materials Characterization Center Inc, San Juan | 2015

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Nantong Tianlong Animal By-products Co., Ltd, Nantong | 2014

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Changzhou Qianhong Bio Pharma Co., Ltd., Changzhou | 2014

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Boai NKY Pharmaceuticals Ltd., Jiaozuo | 2014

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Boai NKY Pharmaceuticals Ltd., Jiaozuo | 2014

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Yunnan Hande Bio-Tech Co., Ltd., Kunming | 2014

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd., Shijiazhuang | 2014

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd., Shijiazhuang | 2014

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Glaxo Wellcome S.A., Aranda de Duero | 2013

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Roche S.p.A., Segrate | 2013

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Roche S.p.A., Milano | 2013

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Minakem SAS, Beuvry La Foret | 2013

Out-of-stock
Ivis L. Negron Torres
Animal Drugs & Feed Form 483

FDA 483 Minakem Beuvry Production, Beuvry la Foret | 2013

Out-of-stock
Ivis L. Negron Torres
Animal Drugs & Feed Form 483

FDA 483 Blu Caribe Inc, Dorado | 2012

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Gland Pharma Limited, Hyderabad | 2012

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 Fresenius Kabi Oncology Limited (Baddi), Baddi | 2012

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

FDA 483 JMS Singapore PTE Ltd., Singapore | 2012

Out-of-stock
Ivis L. Negron Torres
Human Drug Form 483

Co-Investigators (51)